CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shin, H.-s.
Right arrow Articles by Heo, T.-r.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shin, H.-s.
Right arrow Articles by Heo, T.-r.

Clinical and Diagnostic Laboratory Immunology, January 2001, p. 9-13, Vol. 8, No. 1
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.1.9-13.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Pretreatment of Whole Blood for Use in Immunochromatographic Assays for Hepatitis B Virus Surface Antigen

Hyeong-soon Shin,1 Chang-kyu Kim,2 Kwang-soon Shin,3 Hong-keun Chung,4 and Tae-ryeon Heo1,*

Department of Biological Engineering, Inha University, Inchon 402-751,1 Konkuk University Animal Resources Research Center, Seoul 143-701,2 Department of Veterinary Medicine, Chungnam National University, Daejon 305-764,3 and Department of Biochemistry, College of Medicine, Seoul National University, Seoul 110-744,4 Korea

Received 14 April 2000/Returned for modification 15 June 2000/Accepted 28 September 2000

Immunochromatographic assays (ICAs) are also referred to as rapid tests, since they are simple and the results can be obtained within minutes after manually loading a few drops of a sample into each sample well of the test device. However, whole blood cannot be tested with ICA kits due to the visual hindrance caused by the color of red blood cells (RBCs), unless a cell-removing device such as a filter is mounted on the kits. Thus, when testing with blood, the advantage of the ICA kit is lost because of the additional time and machines required to coagulate and separate whole blood before preparing the serum. To overcome this limitation, whole-blood samples were added to a pretreatment solution to decolor the RBCs; the resulting mixtures were then loaded into the sample wells of the test device. The pretreating solution was composed of hydrogen peroxide (H2O2) to decolor the RBCs, Sag 471 (Osi Specialties) to restrain the mixture from vigorous foaming, sodium azide (NaN3) to inhibit the enzyme, which generates excessive foam at the beginning of decolorization, and EDTA as a chelating agent. As a result of this pretreatment, whole blood could be used with the ICA kit without reducing its simplicity and rapidity.


* Corresponding author. Mailing address: Department of Biological Engineering, Inha University, Younghyun-dong 253, Nam-gu, Inchon 402-751, Korea. Phone: 82-32-860-7511. Fax: 82-32-875-0827. E-mail: theo{at}inha.ac.kr.


Clinical and Diagnostic Laboratory Immunology, January 2001, p. 9-13, Vol. 8, No. 1
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.1.9-13.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2001 by the American Society for Microbiology. All rights reserved.